- Home
- MCK
as 11-15-2024 4:00pm EST
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
| Founded: | 1833 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 71.3B | IPO Year: | N/A |
| Target Price: | $623.62 | AVG Volume (30 days): | 990.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 19.33 | EPS Growth: | -23.76 |
| 52 Week Low/High: | $431.35 - $637.51 | Next Earning Date: | 11-06-2024 |
| Revenue: | $330,187,000,000 | Revenue Growth: | 13.43% |
| Revenue Growth (this year): | 17.07% | Revenue Growth (next year): | 8.64% |
Stock Insider Trading Activity of McKesson Corporation (MCK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| TYLER BRIAN S. | MCK | Chief Executive Officer | Sep 5 '24 | Sell | $561.10 | 3,753 | $2,105,808.30 | 78,586 |
Latest McKesson Corporation News
MCK Breaking Stock News: Dive into MCK Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Investors Can Find Comfort In McKesson's (NYSE:MCK) Earnings Quality
Investor's Business Daily
4 days ago
McKesson Stock Gets A RS Rating Lift To 75
MT Newswires
4 days ago
Market Chatter: Baltimore Wins $266 Million in Lawsuit Against Opioid Distributors
Zacks
5 days ago
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
Reuters
5 days ago
Baltimore wins $266 million in opioid case against distributors
Zacks
5 days ago
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Zacks
5 days ago
McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?
MT Newswires
5 days ago
Citigroup Adjusts Price Target on McKesson to $713 From $630, Maintains Buy Rating
Compare MCK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MCK McKesson Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.